To dissociate the impact of p53 and Atm on genomic stability, we grouped the Atm-null cancer cell lines into those with mutant p53 and those with functional p53 (treatment with the MDM2 inhibitor nutlin confirmed the presence or absence of functional p53, see Supplementary Fig. S6). The gene discussed is TP53; the disease is cancer.